Dr. Atul Ashok Khasnis, MD

Dr. Khasnis practices at American Arthritis & Rheumatology Associates-GA in Newnan, Georgia.

Dr. Khasnis' NPI, 1639292931, was assigned on April 9, 2007. Dr. Khasnis holds Georgia license 73311.

Dr. Khasnis' primary practice is American Arthritis & Rheumatology Associates-GA, at 184 Jefferson Pkwy, Newnan, GA 30263 in Coweta County. The practice phone is (770) 887-5159.

Dr. Khasnis' primary practice is American Arthritis & Rheumatology Associates-GA in Newnan, Georgia. Dr. Khasnis is also affiliated with Piedmont Newnan Hospital. The medical group on file is Georgia Rheumatology Clinic. Dmand AI also links Dr. Khasnis to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khasnis practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Khasnis' primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Khasnis is licensed in Georgia.

CMS data shows 8,134 Medicare services from Dr. Khasnis across 16 procedure codes in 2024, for 549 Medicare patients. Medicare paid $217,324 for them. Every service was in an office.

CMS counts 549 Medicare patients who saw Dr. Khasnis in 2024. The largest group is 65 to 74, with 263 patients. 75% of them have arthritis, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Khasnis' median patient age at 64, with 76% women.

In 2024, Dr. Khasnis wrote 3,093 Medicare Part D claims for 610 patients. 87% of them were for generic drugs. CMS names the drug for 2,821 of them, across 31 drugs with 11 or more claims each, at $1,332,611 in total drug cost. In 2023, CMS named 1,930 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Khasnis for performance year 2024, reported as part of a group. Dr. Khasnis accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Khasnis, published from 2011 to 2015. 2011 was the busiest year, with 2. The most frequent topics are Glucocorticoids, Drug Therapy, Combination and Hydroxychloroquine. Dr. Khasnis' most frequent co-authors are Tahmeed Akil Contractor, MD, Lama Azar, MD and Carmen E. Gota, MD.

Dmand AI links Dr. Khasnis to 1 clinical trial. Open Payments lists research payments to Dr. Khasnis that name 1 trial.

CMS Open Payments shows 97 general payments to Dr. Khasnis from 17 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 71% of the total. UCB, Inc. paid the most, $9,632. It also lists 1 research payment totaling $50 in 2017, naming 1 clinical trial.